Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells

Guía clínica del carcinoma urotelial no músculo invasivo de la Asociación Europea de Urología

(2013) Marko Babjuk et al.   Actas Urologicas Espanolas

Human leukocyte antigen class I down-regulation in muscle-invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy

(2009) Ichiya Homma et al.   CANCER SCIENCE

Adoptive cell therapy for the treatment of patients with metastatic melanoma

(2009) Steven A Rosenberg et al.   CURRENT OPINION IN IMMUNOLOGY

Long-term Efficacy of Maintenance Bacillus Calmette-Guérin versus Maintenance Mitomycin C Instillation Therapy in Frequently Recurrent TaT1 Tumours without Carcinoma In Situ: A Subgroup Analysis of the Prospective, Randomised FinnBladder I Study with a 20-Year Follow-up

(2009) Riikka Järvinen et al.   EUROPEAN UROLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer

(2009) Alain Bergeron et al.   INTERNATIONAL JOURNAL OF CANCER

Efficacy of Bacille Calmette-Guérin Immunotherapy Predicted by Expression of Antigen-presenting Molecules and Chemokines

(2009) Paula A. Videira et al.   UROLOGY

Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

(2008) Natalia Aptsiauri et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

(2008) Barbara Seliger   CANCER IMMUNOLOGY IMMUNOTHERAPY

Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

(2008) Rafael Carretero et al.   IMMUNOGENETICS

Immune Responses Detected in Urothelial Carcinoma Patients After Vaccination With NY-ESO-1 Protein Plus BCG and GM-CSF

(2008) Padmanee Sharma et al.   JOURNAL OF IMMUNOTHERAPY

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

(2008) Tomasz Demkow et al.   UROLOGIA INTERNATIONALIS